Clinical Trials
11
Active:1
Completed:9
Trial Phases
3 Phases
Phase 1:1
Phase 3:1
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (50.0%)Phase 1
1 (25.0%)Phase 3
1 (25.0%)INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With Schizophrenia
- First Posted Date
- 2008-06-16
- Last Posted Date
- 2014-04-28
- Lead Sponsor
- Janssen-Cilag B.V.
- Target Recruit Count
- 27
- Registration Number
- NCT00697658
The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease
Phase 3
Completed
- Conditions
- Anemia
- First Posted Date
- 2007-03-13
- Last Posted Date
- 2011-02-01
- Lead Sponsor
- Janssen-Cilag B.V.
- Target Recruit Count
- 176
- Registration Number
- NCT00446576
VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands
- First Posted Date
- 2007-02-27
- Last Posted Date
- 2014-01-14
- Lead Sponsor
- Janssen-Cilag B.V.
- Target Recruit Count
- 331
- Registration Number
- NCT00440765
ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.
- First Posted Date
- 2007-02-27
- Last Posted Date
- 2015-04-16
- Lead Sponsor
- Janssen-Cilag B.V.
- Target Recruit Count
- 11
- Registration Number
- NCT00440479
Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)
- First Posted Date
- 2006-11-14
- Last Posted Date
- 2012-11-06
- Lead Sponsor
- Janssen-Cilag B.V.
- Target Recruit Count
- 1927
- Registration Number
- NCT00398749
- Prev
- 1
- 2
- Next
News
No news found